Could PharmaCan Capital Corp Crash Even More? The Stock Had Another Big Decline Today

 Could PharmaCan Capital Corp Crash Even More? The Stock Had Another Big Decline Today

The stock of PharmaCan Capital Corp (CVE:MJN) is a huge mover today! About 569,949 shares traded hands. PharmaCan Capital Corp (CVE:MJN) has risen 6.00% since October 23, 2016 and is uptrending. It has outperformed by 1.44% the S&P500.
The move comes after 9 months negative chart setup for the $215.54M company. It was reported on Nov, 22 by Barchart.com. We have $1.43 PT which if reached, will make CVE:MJN worth $10.78 million less.

More important recent PharmaCan Capital Corp (CVE:MJN) news were published by: Marketwatch.com which released: “Jason Adler Announces Increase in Equity Interest in PharmaCan Capital Corp.” on June 08, 2016, also Midasletter.com published article titled: “PharmaCan Capital Corp (TSX.V:MJN) CEO Paul Rosen Interview and Podcast”, Marketwired.com published: “PharmaCan Capital Corp. to Open Toronto Stock Exchange” on January 13, 2015. More interesting news about PharmaCan Capital Corp (CVE:MJN) was released by: Marketwired.com and their article: “PharmaCan Capital Corp. Announces Approval of Increased Production Expansion …” with publication date: April 01, 2015.

PharmaCan Capital Corp., formerly Searchtech Ventures Inc., is a merchant bank, which is focused on investing in Canada’s medical marijuana industry. The company has a market cap of $215.54 million. The Firm is engaged in the business of investing in companies either licensed or seeking a license to produce medical marijuana. It currently has negative earnings. The Firm operates through two divisions: Investing Segment and Operating Segment.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment